

( (S (NP-SBJ-1 This)
     (VP is
         (VP written
             (NP *-1)
	     (S-PRP (NP-SBJ *)
		    (VP to
			(VP correct
			    (NP (NP a misquotation)
				(PP-LOC in
					(NP (NP your Oct. 3 article)
					    ``
					    (NX-TTL (S (NP-SBJ-2 (NP Deaths)
								 (PP From
								     (NP Advanced Colon Cancer)))
						       (VP Can
							   (VP Be
							       (VP Reduced
								   (NP *-2)
								   (PP-MNR by
									   (S-NOM (NP-SBJ *)
										  (VP Using
										      (NP Two Drugs)))))))))))))))))
     . ''))
( (S (PP-LOC In
	     (NP this article))
     ,
     (NP-SBJ-1 I)
     (VP was
         (VP alleged
             (S (NP-SBJ *-1)
                (VP to
                    (VP have
                        (VP said ,
                            (SBAR 0 ``
                                  (S (NP-SBJ (NP Any patient)
                                             (PP with
                                                 (NP high-risk colon cancer)))
                                     (VP is
                                         (ADVP really)
                                         (VP getting
                                             (NP short shrift)
					     (SBAR-ADV if
						       (S (NP-SBJ he)
							  (VP 's not
							      (VP getting
								  (NP this therapy)))))))))))))))
     . ''))
( (S (S (NP-SBJ I)
        (VP did n't
            (VP say
                (NP this))))
     , and
     (S (NP-SBJ I)
        (VP 'm
            (VP (ADVP totally)
                opposed
                (PP to
                    (NP (NP the philosophy)
                        (VP expressed
                            (NP *)
                            (PP by
                                (NP-LGS the quote))))))))
     .))
( (S (NP-SBJ I)
     (VP (VP have not
	     (VP offered))
	 and
	 (VP will not
	     (VP offer
		 (NP (NP routine therapy)
		     (PP with
			 (NP (NP the two drugs)
			     ,
			     (NP levamisole and 5-fluorouracil))))
		 ,
		 (PP-DTV to
			 (NP (NP any)
			     (PP of
				 (NP my colon-cancer patients)))))))
     .))
( (S (S (PP-MNR With
		(NP this treatment))
        (NP-SBJ we)
        (VP have
            (VP reduced
                (NP (NP deaths)
                    (PP in
                        (NP high-risk colon cancer)))
                (PP-EXT by
			(NP one-third)))))
     -- but
     (S (NP-SBJ this)
        (VP leaves
            (NP (NP the two-thirds)
                (SBAR (WHNP-1 who)
                      (S (NP-SBJ *T*-1)
                         (VP are
                             (VP dying
                                 (PP-CLR of
					 (NP cancer)))))))))
     .))
( (S (NP-SBJ This)
     (VP is not
         (ADJP-PRD nearly good enough))
     .))
( (S (NP-SBJ I)
     (VP believe
         (SBAR 0
               (S (NP-SBJ (NP any physician)
                          (SBAR (WHNP-1 who)
                                (S (NP-SBJ *T*-1)
                                   (ADVP truly)
                                   (VP cares
                                       (PP-CLR about
					       (NP cancer patients))
				       ,
				       (NP-TMP both today and tomorrow)))))
                  ,
                  (VP should
                      (VP offer
                          (NP (NP the hope)
                              (PP of
                                  (NP (NP something)
                                      (ADJP (ADJP better)
                                            (PP than
                                                (NP that)))))))))))
     .))
( (S (NP-SBJ (NP My statement)
             ,
             (VP read
                 (ADVP-MNR verbatim)
                 (PP from
                     (NP (NP a printed text)
                         (ADJP available
                               (PP to
                                   (NP (NP all reporters)
                                       (VP attending
                                           (NP the National Cancer Institute news conference))))))))
             ,)
     (VP was
         (NP-PRD (NP the following)
                 : ``
                 (S (NP-SBJ-1 New clinical trials)
                    (VP are
			(ADVP-TMP already)
			(PP-PRD in
				(NP operation))
			(S-ADV (NP-SBJ *-1)
			       (VP seeking
				   (S (NP-SBJ *)
				      (VP to
					  (VP improve
					      (NP these results))))))))))
     .))
( (S (NP-SBJ These research protocols)
     (VP offer
         (PP-DTV to
		 (NP the patient))
         (NP not only
             (NP (NP the
                     (ADJP very best)
                     therapy)
                 (SBAR (WHNP-1 which)
                       (S (NP-SBJ we)
                          (VP have
                              (VP established
                                  (NP *T*-1)
				  (NP-TMP today))))))
             but also
             (NP (NP the hope)
                 (PP of
                     (NP (NP something)
                         (ADJP still better))))))
     .))
( (S (NP-SBJ I)
     (VP feel
         (SBAR 0
               (S (NP-SBJ (NP any patient)
                          (PP with
                              (NP high-risk cancer)))
                  (VP is
                      (VP getting
                          (NP short shrift)
			  (SBAR-ADV if
				    (S (NP-SBJ he)
				       (VP is not
					   (VP offered
					       (NP this opportunity))))))))))
     . ''))
( (S (NP-SBJ We)
     (VP have
         (NP (NP (ADJP very exciting)
		 prospects)
	     (PP for
                 (NP (NP (ADJP far more impressive)
			 advances)
		     (PP-LOC in
			     (NP (NP the treatment)
				 (PP of
				     (NP colon cancer))))))
	     (PP-TMP during
		     (NP (NP the years)
			 (ADJP immediately ahead)))))
     .))
( (S (NP-SBJ-1 This hope)
     ,
     (ADVP however)
     ,
     (VP will
         (ADVP-TMP never)
         (VP be
             (VP realized
                 (NP *-1)
		 (SBAR-ADV if
			   (S (NP-SBJ we)
			      (VP use
				  (NP levamisole and 5-fluorouracil)
				  (PP-CLR as
					  (NP a stopping point))))))))
     .))
( (NP-HLN (NP Charles G. Moertel M.D .)
	  (NP (NP Mayo Clinic)
	      (NP (NP Rochester)
		  ,
		  (NP Minn)))
	  .))
